Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nature Medicine publishes phase 3 anakinra study results in patients with COVID-19 pneumonia

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and the Hellenic Institute for the Study of Sepsis today announce that Nature Medicine has published positive results from the investigator-sponsored phase 3 SAVE-MORE study evaluating anakinra plus standard of care (SOC) in patients with moderate-to-severe COVID-19 pneumonia. The study demonstrated that early and targeted use of anakinra, in addition to current SOC, reduces risk of death, reduces ICU admission and increases likelihood of full recovery in hospitalised COVID-19 patients with poor prognosis due to risk of severe

Acceleration Software and the History of Strategy Execution Software – #2 The Real-time Era

In a series of three blog posts, we’ll dig into the history of strategy execution, trends, and platforms. After the initial post – the Reactive era  – it’s time to put the real-time era in the spotlight.#2 The Real-Time Era After a deep dive into the emergence of the digital era. we’ll move on to what we call “the Real-Time Era” and its Proactive software.Growing tired of the slow and reactive nature of the first strategy execution platforms, a second wave was emerging building on more agile traits. A new way

NENT Group and Play sign Polish Viaplay distribution partnership

· Viaplay included in new PLAY NOW TV subscriptions and available free to current subscribers until end of January 2022 · Play’s millions of mobile postpaid customers can choose to access Viaplay for a free trial period · Viaplay’s Polish offering spans Viaplay Originals, international films and series, kids content and premium live sports Nordic Entertainment Group (NENT Group) and Poland’s leading mobile operator Play have agreed a multi-year distribution deal that makes NENT Group’s Viaplay streaming service broadly available to Play’s millions of postpaid subscribers. Viaplay

Axel Johnson International strengthens its offering in Driveline Solutions

Axel Johnson International’s business group Driveline Solutions strengthens its position in the filter and hydraulic cylinder segments through the acquisition of Swedish-based company MIAS Group.“The acquisition of MIAS Group is well in-line with our strategy to strengthen our offering in products and services complementary to our mobile and industrial driveline solutions. MIAS Group is a well-run and profitable company, and through this acquisition we will be able to grow our existing Swedish filter business,” says Jan Brattberg, Managing Director, Driveline Solutions. MIAS Group

DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report for QIXLEEF™

COPENHAGEN, Denmark, 03 September 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma”) hereby on behalf of Tetra Bio-Pharma Inc. (“Tetra”), announce that Tetra Bio-Pharma - a leader in cannabinoid-derived drug discovery and development – yesterday announced that Tetra has received the Scientific Advice Assessment (SAA) Report from the Malta Medicines Authority.DanCann Pharma signed May 5th a definitive distribution agreement with Canadian Tetra Bio-Pharma Inc. concerning the exclusive distribution of the cannabinoid-based medicines Reduvo™ Adversa® and Qixleef™ in Denmark, Norway,

Acceleration Software and the History of Strategy Execution Software – #1 The Reactive Era

In a series of three blog posts, we’ll dig into the history of strategy execution, trends, and platforms.Generally speaking, strategy execution software has been around as long as strategies. This of course is not completely true, but with the emergence of the digital era, companies have been searching for the best way to get help from software when it comes to their strategy execution efforts.Looking back at the last 25 years of digital platforms and their inherit traits, there are some clear trends. These can be divided into three different eras, where each and everyone will get a

RaySearch's CFO Peter Thysell has resigned

RaySearch Laboratories AB (publ) CFO Peter Thysell has resigned from his role to take on the role of CFO of another company. Peter Thysell will continue in his current role during the notice period of three months to ensure an orderly transition until a new CFO takes over. The process to recruit his successor has begun.“We thank Peter for his contributions to RaySearch during the past six years and wish him the best in his new endeavours” says Johan Löf, CEO of RaySearch.

Cary Group continues to implement actions to reduce carbon emissions

Cary Group provides car care services that sustain the life, value and safety features of vehicles. Caring and repairing, instead of replacing, with social responsibility and minimal environmental impact, is the foundation of sustainable car care at Cary Group. Sustainability is integrated in each step of the windshield’s journey at Cary Group, from the first interaction with the customer after a stone chip has occurred, to the damage assessment, through the repair or replacement process until the windshield is repaired and recycled. From August Cary Group has decided to provide electric

Europi Property Group and Pi Labs, Europe’s leading PropTech VC firm, enter a strategic partnership

Europi Property Group invests in Europe’s leading PropTech VC firm Pi Labs’ third fund, which intends to invest SEK 700 million within three years. The partnership involves an active collaboration with the VC firm, with Europi Property Group and Brunswick Ventures becoming strategic partners in the Nordic region“We’ve gotten to know Pi Labs over the past year and are very impressed with their research and data-driven investment strategy and the high returns of their past funds. For Europi, innovation and entrepreneurship are key core values that are driving much-needed further development

Avida is gearing up - sees great growth potential in the Nordic corporate market.

With the goal of becoming one of the leading specialist lenders in the Nordic region in both consumer and business finance, Avida is undertaking strategic investments in its business finance footprint so as to take advantage of the great growth potential that exists in the Nordic corporate market.This investment comes as a result of the strategy review that the board and management team of the company conducted during the first half of this year. Varun Khanna, Chairman of the Board of Avida and representative of the company's main shareholder, KKR, says: “We believe that there is a

Shaikan Payment Update

3 September 2021 Gulf Keystone Petroleum Ltd. (LSE: GKP)("Gulf Keystone", "GKP" or "the Company")  Shaikan Payment Update Gulf Keystone confirms that a gross payment of $37.6 million ($29.5 million net to GKP) has been received from the Kurdistan Regional Government ("KRG"). The payment is comprised of gross $31.7 million ($24.8 million net) for Shaikan crude oil sales during June 2021 and gross $6.0 million ($4.7 million net) in relation to the arrears from the outstanding November 2019 to February 2020 invoices. Following receipt of the arrears payment calculated based on

CS MEDICA A/S issue of units prior to listing was oversubscribed

On August 31[st], 2021, the subscription period in CS MEDICA A/S’s (”CS MEDICA” or the ”Company”) IPO of units (shares and consideration free warrants) prior to the planned listing on Spotlight Stock Market ended. The initial part of the IPO of units was subscribed to a total of approximately DKK 35.2 million, corresponding to a subscription ratio of approximately 158 percent. The Company will thus receive approximately DKK 22.3 million of which approximately DKK 3.9 million pertains to bridge loan, and approximately DKK 0.8 million is attributable to compensation (in the form of units) to

Hynion and Hyrex to cooperate on hydrogen stations for leisure boats

Hynion AS and Hyrex AS will cooperate to expand hydrogen filling stations for leisure boats. Hyrex has developed HyCruiser 28, a day cruiser with a hydrogen-electric powertrain.“As Hynion now builds a network of hydrogen filling stations in Norway and Sweden, we see exciting opportunities in ports as well. Although other forms of transport account for more emissions than recreational boats, this is also a significant segment, and the Norwegian authorities have stated clearly that emissions from recreational boats should be halved. It’s very hard to see how this could happen without the use

Multiple PSV contracts in West Africa

Solstad Offshore ASA is pleased to announce multiple new medium-term contracts in West Africa. Letter of Agreements have been signed with key clients for 7 PSVs, all with commencement Q4 2021 / Q1 2022. The total firm duration of the contracts is approximately 1,000 vessel days with options to extend the contracts further. Skudeneshavn, September 3[rd], 2021 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASAwww.solstad.com

Preem invests heavily in rapid charging

The fuel company Preem is investing heavily in rapid charging and has signed an agreement with Recharge to install hundreds of rapid chargers at Preem's stations throughout the country.Preem is now developing its stations together with the leading charging operator Recharge. Preem's stations will initially be equipped with four to eight charging points that will have an output of 150 kW up to 300 kW, which enables considerably faster charging. “This is part of Preem's renewable transition and our strategy to offer more environmentally efficient forms of energy at our stations. By

Trill Impact raises EUR 900 million for its inaugural Fund

Trill Impact has closed EUR 900 million in commitments for its inaugural impact mid-market buyout Fund (“the Fund”) from prominent institutional investors globally, making it one of the largest first-time-funds raised during the COVID-19 pandemic by an independent private investments firm.Trill Impact was founded in 2019 by Jan Ståhlberg and is today one of the largest dedicated impact investing houses in Europe with more than EUR 1 billion in assets under management across its private equity and microfinance investment advisory strategies. Despite the fundraising occurring in

Bio-Works adds distributor coverage in Croatia and Slovenia in deal with BIA d.o.o.

Bio-Works Technologies AB (Uppsala, Sweden) and BIA d.o.o. (Ljubljana, Slovenia) have signed a distribution agreement through which BIA will provide Bio-Works' next generation chromatography resins and prepacked columns to customers in Croatia and Slovenia.  Bio-Works' patented resins, WorkBeads™, are well-suited not only for the purification of biological compounds at laboratory scale but also for biopharmaceuticals at large scale, including peptides and recombinant proteins. Bio-Works has a broad portfolio of resin technology, including immobilized affinity chromatography (IMAC), size

Heimstaden Issues EUR 400m Senior Unsecured Bond

Heimstaden AB yesterday successfully issued a EUR 400 million fixed rate senior unsecured bond under its MTN programme with a maturity of 5.5 years. The bond carries an annual coupon of 4.375% and a yield of 4.500%. An application will be made for the bond to be listed on Nasdaq Stockholm. The final listing particulars, once published, will be made available on www.heimstaden.com. J.P. Morgan and Swedbank acted as Joint Bookrunners for the issue.  Contact:Arve Regland, CFO+47 47 90 77 00arve.regland@heimstaden.com Adam Lindh, Head of Treasury+46 708-83 96 74adam.

Holmström Fastigheter Holding’s subsidiary F Holmström Holding 6 AB completes the public offer to the sharesholders of Magnolia Bostad

F Holmström Holding 6 AB, reg.no. 559279-7376 (“FHH”), a company which together with inter alia Holmström Fastigheter Holding AB (publ), reg.no. 559286-6809 (“Holmström Holding”) is included in Holmströmgruppen, announced on 7 July 2021 a recommended cash offer to the shareholders of Magnolia Bostad AB, reg.no. 556797-7078 (“Magnolia Bostad” or “the Company”) to tender all of their shares in Magnolia Bostad to FHH (the “Offer”). FHH has today announced the outcome after the extended acceptance period and that the Offer is completed. Furthermore, FHH has announced an offer to acquire

Scandinavian ChemoTech is carrying out a directed new share issue and will receive approximately MSEK 18

Scandinavian ChemoTech AB (publ) (“ChemoTech” or “the Company”) hereby announces that the Company has carried out a directed new share issue which will provide the Company with approximately MSEK 18 before transaction costs. The capital injection enables an upshift of the Company's long-term strategy.The Board of ChemoTech has, with the support of authorisation from the Annual General Meeting on May 24, 2021, decided on a directed new issue of 874,211 Series B shares at a subscription price of SEK 20.59 per share. The subscription price corresponds to a discount of approximately 15 percent

BoMill’s long-term incentive program for employees fully subscribed

On May 6, 2021, the Annual General Meeting of BoMill AB resolved on an long-term incentive program through a directed issue of 200,000 warrants of series B 2021-2024 that entitles senior executives and other employees of BoMill the right to subscribe for new shares in the company. The last day for subscription of warrants was August 30, 2021, and the directed issue of warrants was fully subscribed.The purpose of the incentive program is to strengthen the employees of the company´s interest and incentives for the company’s financial growth. The rights to subscribe were offered to the CEO and

Lipum’s toxicology- and safety studies on the candidate drug SOL-116 progress according to plan

Press release: Umeå, September 3, 2021. The dose-finding toxicology- and safety studies on Lipum’s candidate drug (SOL-116) have been completed according to plan and the final Clinical Trial Application (CTA)-enabling toxicology study has now started.The non-clinical program for toxicology- and safety studies of Lipum’s candidate drug (SOL-116) is carried out in collaboration with the contract research organisation (CRO) Charles River Laboratories. Previous dose finding studies, which included various dose levels, were conducted in two different species with a treatment period of four weeks.

Realheart enters partnership with software experts Codialist

Realheart's artificial heart consists of two parts: an internal heart unit and an external control unit that is the brain of the system. The control unit software is now being tested to develop the final version in preparation for human clinical trials. This is being done in collaboration with medical device software experts Codialist.Codialist is a software development firm for medical devices with special expertise in heart pump technologies having been spun off from Berlin Heart GmbH, a world-leading German manufacturer of assistive devices for patients with end-stage heart failure.

There are no items matching the current filter
There are no more items matching the current filter
Back to top